Medical Equipment Maker Thermo Fisher Scientific Clocks 7% Decline In Q4 Organic Sales, Issues Subdued Annual Outlook – Thermo Fisher Scientific (NYSE:TMO)
Wednesday, Thermo Fisher Scientific Inc (NYSE: TMO) posted a fourth-quarter revenue of $10.89 billion, down 5% year-on-year (Y/Y), beating the consensus of $10.73 billion. Organic revenue was 7% lower, Core organic revenue growth declined…